BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 25041240)

  • 1. Endocannabinoid modulation by FAAH and monoacylglycerol lipase within the analgesic circuitry of the periaqueductal grey.
    Lau BK; Drew GM; Mitchell VA; Vaughan CW
    Br J Pharmacol; 2014 Dec; 171(23):5225-36. PubMed ID: 25041240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.
    Guindon J; Lai Y; Takacs SM; Bradshaw HB; Hohmann AG
    Pharmacol Res; 2013 Jan; 67(1):94-109. PubMed ID: 23127915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitors of monoacylglycerol lipase, fatty-acid amide hydrolase and endocannabinoid transport differentially suppress capsaicin-induced behavioral sensitization through peripheral endocannabinoid mechanisms.
    Spradley JM; Guindon J; Hohmann AG
    Pharmacol Res; 2010 Sep; 62(3):249-58. PubMed ID: 20416378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain.
    Kinsey SG; Long JZ; O'Neal ST; Abdullah RA; Poklis JL; Boger DL; Cravatt BF; Lichtman AH
    J Pharmacol Exp Ther; 2009 Sep; 330(3):902-10. PubMed ID: 19502530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of fatty acid amide hydrolase and monoacylglycerol lipase inhibitor treatments on lipopolysaccharide-induced airway inflammation in mice.
    Abohalaka R; Bozkurt TE; Nemutlu E; Onder SC; Sahin-Erdemli I
    Pulm Pharmacol Ther; 2020 Jun; 62():101920. PubMed ID: 32416152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral antinociceptive effects of inhibitors of monoacylglycerol lipase in a rat model of inflammatory pain.
    Guindon J; Guijarro A; Piomelli D; Hohmann AG
    Br J Pharmacol; 2011 Aug; 163(7):1464-78. PubMed ID: 21198549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of fatty acid amide hydrolase unmasks CB1 receptor and TRPV1 channel-mediated modulation of glutamatergic synaptic transmission in midbrain periaqueductal grey.
    Kawahara H; Drew GM; Christie MJ; Vaughan CW
    Br J Pharmacol; 2011 Jul; 163(6):1214-22. PubMed ID: 21175570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoid CB
    Leonard MZ; Alapafuja SO; Ji L; Shukla VG; Liu Y; Nikas SP; Makriyannis A; Bergman J; Kangas BD
    J Pharmacol Exp Ther; 2017 Dec; 363(3):314-323. PubMed ID: 28947487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the cannabinoid system for pain relief?
    Chiou LC; Hu SS; Ho YC
    Acta Anaesthesiol Taiwan; 2013 Dec; 51(4):161-70. PubMed ID: 24529672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple Forms of Endocannabinoid and Endovanilloid Signaling Regulate the Tonic Control of GABA Release.
    Lee SH; Ledri M; Tóth B; Marchionni I; Henstridge CM; Dudok B; Kenesei K; Barna L; Szabó SI; Renkecz T; Oberoi M; Watanabe M; Limoli CL; Horvai G; Soltesz I; Katona I
    J Neurosci; 2015 Jul; 35(27):10039-57. PubMed ID: 26157003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo.
    Long JZ; Nomura DK; Vann RE; Walentiny DM; Booker L; Jin X; Burston JJ; Sim-Selley LJ; Lichtman AH; Wiley JL; Cravatt BF
    Proc Natl Acad Sci U S A; 2009 Dec; 106(48):20270-5. PubMed ID: 19918051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of 2-arachidonoylglycerol hydrolysis by selective monoacylglycerol lipase inhibitor 4-nitrophenyl 4-(dibenzo[d][1,3]dioxol-5-yl(hydroxy)methyl)piperidine-1-carboxylate (JZL184) Enhances retrograde endocannabinoid signaling.
    Pan B; Wang W; Long JZ; Sun D; Hillard CJ; Cravatt BF; Liu QS
    J Pharmacol Exp Ther; 2009 Nov; 331(2):591-7. PubMed ID: 19666749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the basolateral nucleus of the amygdala in endocannabinoid-mediated stress-induced analgesia.
    Connell K; Bolton N; Olsen D; Piomelli D; Hohmann AG
    Neurosci Lett; 2006 Apr; 397(3):180-4. PubMed ID: 16378681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid type-1 receptors.
    Maione S; Bisogno T; de Novellis V; Palazzo E; Cristino L; Valenti M; Petrosino S; Guglielmotti V; Rossi F; Di Marzo V
    J Pharmacol Exp Ther; 2006 Mar; 316(3):969-82. PubMed ID: 16284279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB
    Owens RA; Mustafa MA; Ignatowska-Jankowska BM; Damaj MI; Beardsley PM; Wiley JL; Niphakis MJ; Cravatt BF; Lichtman AH
    Neuropharmacology; 2017 Oct; 125():80-86. PubMed ID: 28673548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocannabinoids at the spinal level regulate, but do not mediate, nonopioid stress-induced analgesia.
    Suplita RL; Gutierrez T; Fegley D; Piomelli D; Hohmann AG
    Neuropharmacology; 2006 Mar; 50(3):372-9. PubMed ID: 16316669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocannabinoids control vesicle release mode at midbrain periaqueductal grey inhibitory synapses.
    Aubrey KR; Drew GM; Jeong HJ; Lau BK; Vaughan CW
    J Physiol; 2017 Jan; 595(1):165-178. PubMed ID: 27461371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of CB
    Karwad MA; Couch DG; Theophilidou E; Sarmad S; Barrett DA; Larvin M; Wright KL; Lund JN; O'Sullivan SE
    FASEB J; 2017 Aug; 31(8):3267-3277. PubMed ID: 28404744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuation of anticipatory nausea in a rat model of contextually elicited conditioned gaping by enhancement of the endocannabinoid system.
    Limebeer CL; Abdullah RA; Rock EM; Imhof E; Wang K; Lichtman AH; Parker LA
    Psychopharmacology (Berl); 2014 Feb; 231(3):603-12. PubMed ID: 24043345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelium-dependent metabolism by endocannabinoid hydrolases and cyclooxygenases limits vasorelaxation to anandamide and 2-arachidonoylglycerol.
    Ho WS; Randall MD
    Br J Pharmacol; 2007 Mar; 150(5):641-51. PubMed ID: 17245358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.